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Mitochondrial myopathy with atypical subacute 
presentation  
Mitochondrial myopathies usually have a chronic course of progressive limb weakness, 
exercise induced myalgia without muscle tenderness, and normal or only mildly raised 
serum creatine kinase.1 Acute or subacute presentation or exacerbation of nervous system 
signs is common in Leber's hereditary optic neuropathy (LHON) and in mitochondrial 
encephalopathy, lactic acidosis, and stroke-like episodes (MELAS),1 but has not been 
reported for muscle in mitochondrial diseases. We describe a patient who presented with 
rapidly progressive, subacute muscle weakness due to a mitochondrial disorder.  
A 38 year old woman presented for the first time with a sudden rapid progression over six 
weeks of myalgia at rest and muscle weakness. She became bedridden just before 
admission. On questioning she reported that for about a year she had some muscle pain 
and a very mild weakness, but continued with all her chores as a mother of six children.  
Physical examination disclosed diffuse and pronounced muscle tenderness and moderate 
to severe proximal limb weakness (3/5 on the MRC scale), with normal strength distally. 
Tendon reflexes were hypoactive. She had no pyramidal signs and her mental functions, 
cranial nerves, sensation, and cerebellar functions were intact. The following laboratory 
tests were normal or negative: blood count, serum electrolytes, liver and renal function 
tests, arterial blood gases, antinuclear factor, complement concentration, serum protein 
electrophoresis, and thyroid hormone and cortisol concentrations. However, her 
erythrocyte sedimentation rate was accelerated (65/115), and serum creatine kinase 
concentrations were slightly raised (146 units, normal <110 units). Serum lactate 
concentration was high at rest (7.8 mM/l, normal <2.0 mM/l), and further increased 
during ischaemic exercise.  
Electrodiagnostic evaluation disclosed a sensory polyneuropathy (conduction velocity of 
32.9 m/s in the right sural nerve), with reduced recruitment, and some large amplitude, 
polyphasic units on EMG of the right quadriceps, tibialis anterior, and gastrocnemius 
muscles. Muscle biopsy disclosed many ragged-red fibres but no inflammation or 
myonecrosis. Electron microscopy confirmed the presence of abnormal mitochondria, 
some of which contained paracrystalline inclusions (figure). NADH cytochrome c 
oxydoreductase, ubiquinol/cytochrome c reductase and cytochrome c oxidase activities in 
muscle homogenate were 59 nmol/min/mg (10% of control values), 1.02 Bmol/min/mg 
(40% of control values), and 1.14 nmol/min/mg.  
(20% of control values), respectively. DNA analysis for the common mutations of 
MERRF (tRNALys position 8344), MELAS (tRNALeu position 3243), and Kearns-Sayre 
syndrome (large deletions) was negative. Treatment with vitamin E (800 mg/day), 
vitamin C (2 g/day), ubiquinone (120 mg/day), and carnitine (330 mg/day) was initiated. 
A dramatic improvement of the patient's muscle strength ensued within a few weeks. 
Three months later only mild weakness without tenderness could be detected and the 
patient was stable, under treatment, throughout a year of follow up. She resumed her 
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normal activities. Further evaluation, a year after initiation of therapy, disclosed only very 
mild proximal limb weakness. A repeated muscle biopsy again showed numerous ragged-
red fibres and reduced activity of the respiratory chain enzymes NADH ferricyanide 
reductase, NADH-cytochrome c oxireductase, cytochrome c oxidase (complex IV), 
NADH-ubiquinone reductase (complex I), and ubiquinol-cytochrome c reductase 
(complex III).  
 
Mitochondria with typical paracrystalline inclusions. 
 
The patient described here presented with subacute onset, at adulthood, of myalgia and 
muscle tenderness at rest, proximal weakness, raised creatine kinase, and accelerated 
erythrocyte sedimentation rate. These features strongly suggested an inflammatory 
myopathy, but serum lactate abnormality and muscle biopsy established the unexpected 
diagnosis of a mitochondrial disease. This patient had two uncommon features for 
primarily mitochondrial myopathies: the subacute mode of presentation and the dramatic 
and rapid response to cofactor therapy. We have seen another two patients with a similar 
subacute presentation of mitochondrial myopathy in whom a less extensive investigation 
was done.  
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Few ragged-red fibres and mitochondrial morphological changes have been reported in 
inflammatory myopathies, including polymyositis, dermatomyositis, and inclusion body 
myositis,2 3 and mitochondrial DNA abnormalities were recently described in patients 
with inclusion body myositis.3 However, these changes are considered secondary and 
their pathophysiological role in the disease is unclear. The absence of any histological 
features of inflammation, necrosis, or rimmed vacuoles, the abnormalities of serum 
lactate concentrations, and the respiratory chain enzymatic abnormalities strongly suggest 
that our patient had a primary mitochondrial disorder.  
Mitochondrial muscle disease usually follows a slowly progressive course attributed to 
dysfunction of oxidative metabolism and mitochondrial energy production.1 The subacute 
presentation, accelerated course, myalgia, and raised erythrocyte sedimentation rate and 
creatine kinase concentrations are therefore very atypical for this disorder. What might be 
the mechanism of such an unusual course of a mitochondrial muscle disease? One 
explanation is that muscle destruction can induce a secondary immune process due to the 
continuous presentation of cytoplasmic or nuclear antigens to the immune system. Such a 
mechanism may account for the few reported cases2 3 of pathological features of 
inflammatory myopathy with ragged-red fibres and mitochondrial DNA abnormalities. 
Nevertheless, muscle biopsies from our patients disclosed no inflammation, a finding that 
could have supported this theory.  
An alternative possibility is that an accelerated necrotic process and the cell destruction 
in the muscle can result from an acute energy crisis. This is supported by the reported 
cases of myoglobinuria in mitochondrial disorders.4 A similar but slower mechanism may 
explain the relatively rapid presentation in our patient, as well as the subacute mode of 
presentation of other mitochondrial disorders such as MELAS and LHON.  
Although clinical improvement was previously reported in mitochondrial disorders after 
cofactor therapy, multiple complex deficiencies are associated with multisystem failure 
and early death.5 A possible explanation for the pronounced improvement after treatment 
in our patient might be the threshold effect and the heteroplasmy phenomenon.1
Theoretically, a critical subgroup of mitochondria with only a mild enzymatic defect may 
regain function after treatment with electron acceptors, the threshold for function is 
obtained and culminates in clinical improvement.  
The atypical presentation in our patient broadens the range of mitochondrial muscle 
disorders to include a polymyositis-like syndrome. It is recommended that blood lactate 
concentration screening would be performed in all patients with subacute onset of muscle 
weakness.  
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